An update on therapy of primary central nervous system lymphoma. Review uri icon

Overview

MeSH Major

  • Central Nervous System Neoplasms
  • Lymphoma

abstract

  • The most important advance in primary central nervous system (CNS) lymphoma treatment has been the convincing data that high-dose methotrexate-based chemotherapy regimens improve survival compared to historical controls treated with radiotherapy alone. However, the optimal treatment approach is still unclear and therapy can be associated with long-term neurotoxicity. Current research focuses on maximizing survival while minimizing neurologic sequelae.

publication date

  • December 2006

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 17124077

Additional Document Info

start page

  • 311

end page

  • 6